Site content: Global

Press Release

Menarini Silicon Biosystems Introduces Use of DEPArray System for Challenging Flow Cytometry Applications at CYTO Congress

Digital cell sorting technology enables greater precision and accuracy for samples with rare targets and low cell counts   Bologna, Italy and Huntingdon Valley, Pa., --...

New CellSearch Data To Be Presented at AACR Deepens Understanding of Metastatic Breast Cancer

Northwestern Researchers Use Gold-Standard Liquid Biopsy Technology to Identify Potential New Biomarker Bologna, Italy and Huntingdon Valley, Pa., MARCH 26, 2019 -- Menarini Silicon...

Menarini Silicon Biosystems Develops New Assay Workflow for Circulating Multiple Myeloma Cells

Technology to Be Introduced at the Molecular Medicine Tri-Conference May Offer Alternative to Invasive Bone Marrow Biopsy for Monitoring Disease Progression Bologna, Italy and...

Single-Cell Genomic Analysis of Blood Cancers to be Highlighted at American Society of Hematology Meeting

DEPArray Technology Used for Detection and Isolation of Lymphoma and Multiple Myeloma Cells Bologna, Italy and Huntingdon Valley, Pa., NOVEMBER 27, 2018 -- Menarini Silicon Biosystems...

Menarini-Silicon Biosystems Completes Acquisition of CELLSEARCH® Assets

Liquid Biopsy Test for Circulating Tumor Cells Marks Its First Entry into U.S. Diagnostics Market BOLOGNA, Italy, and Philadelphia, PA, April 3, 2017 – Menarini-Silicon...

Menarini-Silicon Biosystems to Acquire CELLSEARCH® CTC System

Only FDA-Cleared CTC test to join Company’s Portfolio of Diagnostics Bologna, Italy and San Diego, CA, Dec 20, 2016 - Menarini-Silicon Biosystems today announced they have...

DEPArray™ Single-Cell Isolation Technology Enables Researchers to Develop a Model for Predicting Response to Treatment in Patients with Lung Cancer

Genetic Profiles of Circulating Tumor Cells May Predict Drug Resistance and Clinical Outcomes   BOLOGNA, Italy, and SAN DIEGO, Calif., November 25, 2016 –...